Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 2/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24200933 | 1.00 | HTR2A (0.45) | HTR2AALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL26088728 | 1.00 | HTR2A (0.45) | HTR2AALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL1000819 | 0.86 | UGT2B7 (0.49) | HTR2AHIF1ACYP1A2SLC6A2SLC6A4 | |
| SCHEMBL12511087 | 0.81 | HTR2A (0.48) | HTR2AALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL40806 | 0.81 | ALDH1A1 (0.44) | HTR2AALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL29853842 | 0.79 | ALDH1A1 (0.42) | HTR2AALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL4642610 | 0.79 | ALDH1A1 (0.42) | HTR2AALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL240650 | 0.77 | UGT2B7 (0.47) | HTR2AALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL4642453 | 0.77 | ALDH1A1 (0.41) | HTR2AALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL13180821 | 0.77 | HTR2A (0.45) | HTR2AALDH1A1HSD17B10HIF1ACYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230126856-A1 | REAGENTS FOR RAPID CHIRAL LABELING AND ANALYSIS OF AMINE CONTAINING ENANTIOMERS | WATERS TECHNOLOGIES CORPORATION (US) | 2023-04-27 | — | — | US | disclosed |
| EP-1040090-A1 | PROCESS FOR SEPARATING LINEAR INTERNAL OLEFINS FROM BRANCHED INTERNAL OLEFINS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 2000-10-04 | — | — | EP | disclosed |
| WO-1999029641-A1 | PROCESS FOR SEPARATING LINEAR INTERNAL OLEFINS FROM BRANCHED INTERNAL OLEFINS | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 1999-06-17 | — | — | WO | disclosed |
| EP-0221781-A2 | Benzylamine derivatives, process for production thereof, and use thereof | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1987-05-13 | — | — | EP | disclosed |
| US-4076830-A | TRANQUILIZERS, ANALGESICS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230126856-A1 | REAGENTS FOR RAPID CHIRAL LABELING AND ANALYSIS OF AMINE CONTAINING ENANTIOMERS | AMD1, AADAT, SRM | HTR2A 173/4885ALDH1A1 161/4885HSD17B10 2396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.